Andrea Gabriela Beratarrechea, M.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telemedicine | 10 | 2022 | 2872 | 1.210 |
Why?
|
Argentina | 17 | 2023 | 232 | 1.010 |
Why?
|
Developing Countries | 7 | 2022 | 2815 | 0.670 |
Why?
|
Prehypertension | 2 | 2015 | 61 | 0.630 |
Why?
|
Primary Health Care | 6 | 2023 | 4557 | 0.550 |
Why?
|
Community Health Services | 1 | 2021 | 650 | 0.540 |
Why?
|
Hypercholesterolemia | 3 | 2019 | 1151 | 0.500 |
Why?
|
Biomedical Technology | 1 | 2016 | 220 | 0.460 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15160 | 0.440 |
Why?
|
Preventive Health Services | 1 | 2016 | 575 | 0.380 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5321 | 0.380 |
Why?
|
Hypertension | 9 | 2023 | 8479 | 0.360 |
Why?
|
Metabolic Diseases | 1 | 2016 | 658 | 0.340 |
Why?
|
Public Health | 2 | 2021 | 2602 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11726 | 0.330 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5135 | 0.330 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.310 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2213 | 0.310 |
Why?
|
Antimalarials | 2 | 2023 | 905 | 0.260 |
Why?
|
Life Style | 3 | 2015 | 3835 | 0.250 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3338 | 0.230 |
Why?
|
Research Design | 2 | 2018 | 5984 | 0.220 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.220 |
Why?
|
Disease Management | 1 | 2013 | 2460 | 0.220 |
Why?
|
Latin America | 3 | 2020 | 380 | 0.200 |
Why?
|
Chronic Disease | 2 | 2013 | 9145 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3020 | 0.200 |
Why?
|
Blood Pressure | 7 | 2023 | 8551 | 0.190 |
Why?
|
Capacity Building | 1 | 2023 | 248 | 0.180 |
Why?
|
Guatemala | 2 | 2019 | 142 | 0.170 |
Why?
|
Poverty | 4 | 2019 | 2660 | 0.160 |
Why?
|
Education, Pharmacy | 1 | 2017 | 35 | 0.150 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5749 | 0.140 |
Why?
|
Reminder Systems | 1 | 2019 | 371 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 417 | 0.130 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2278 | 0.130 |
Why?
|
Psychological Theory | 1 | 2015 | 168 | 0.120 |
Why?
|
Home Care Services | 2 | 2018 | 606 | 0.120 |
Why?
|
Health Personnel | 2 | 2019 | 3219 | 0.120 |
Why?
|
Medication Adherence | 2 | 2023 | 2063 | 0.120 |
Why?
|
Medically Uninsured | 1 | 2019 | 853 | 0.110 |
Why?
|
Malaria | 1 | 2023 | 1239 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 592 | 0.110 |
Why?
|
Quality of Life | 4 | 2020 | 12802 | 0.110 |
Why?
|
Peru | 1 | 2015 | 881 | 0.100 |
Why?
|
Humans | 30 | 2023 | 744366 | 0.100 |
Why?
|
Direct Service Costs | 1 | 2011 | 62 | 0.100 |
Why?
|
Morbidity | 1 | 2017 | 1768 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 840 | 0.100 |
Why?
|
Decision Support Techniques | 2 | 2018 | 1956 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 725 | 0.100 |
Why?
|
Health Behavior | 2 | 2014 | 2635 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2488 | 0.090 |
Why?
|
Health Resources | 2 | 2018 | 911 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2019 | 2355 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1125 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4671 | 0.080 |
Why?
|
Middle Aged | 14 | 2020 | 213390 | 0.080 |
Why?
|
Brazil | 2 | 2023 | 1270 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.080 |
Why?
|
Adult | 12 | 2023 | 214052 | 0.080 |
Why?
|
Quality of Health Care | 1 | 2023 | 4369 | 0.070 |
Why?
|
Health Services Research | 1 | 2015 | 1836 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 3255 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2951 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9688 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2494 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2205 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 72296 | 0.070 |
Why?
|
Patient Preference | 1 | 2013 | 889 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5388 | 0.070 |
Why?
|
Self Care | 1 | 2011 | 786 | 0.070 |
Why?
|
Exercise | 2 | 2019 | 5615 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2015 | 5077 | 0.060 |
Why?
|
Male | 15 | 2020 | 350115 | 0.060 |
Why?
|
Biological Products | 1 | 2013 | 860 | 0.060 |
Why?
|
Female | 15 | 2020 | 380193 | 0.060 |
Why?
|
Aged | 9 | 2019 | 163288 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5253 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2013 | 1338 | 0.060 |
Why?
|
Celiac Disease | 1 | 2010 | 785 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8091 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8319 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25039 | 0.050 |
Why?
|
Systems Analysis | 1 | 2022 | 172 | 0.050 |
Why?
|
Insulin | 1 | 2015 | 6582 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2047 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 40075 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13286 | 0.040 |
Why?
|
Adolescent | 3 | 2023 | 85779 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2013 | 3712 | 0.040 |
Why?
|
Urban Health Services | 1 | 2017 | 179 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3922 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2018 | 63107 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2014 | 199 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 1683 | 0.030 |
Why?
|
Transglutaminases | 1 | 2010 | 194 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1123 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15221 | 0.020 |
Why?
|
Hospitals, Community | 1 | 2010 | 347 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2011 | 642 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2971 | 0.020 |
Why?
|
Choice Behavior | 1 | 2013 | 802 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9955 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2013 | 2539 | 0.020 |
Why?
|
Motivation | 1 | 2015 | 1971 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2715 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3208 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
Weight Loss | 1 | 2015 | 2625 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.010 |
Why?
|
Health Policy | 1 | 2015 | 2661 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6459 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23336 | 0.010 |
Why?
|
Autoantibodies | 1 | 2010 | 2036 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Communication | 1 | 2015 | 3750 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3582 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3307 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53290 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7282 | 0.010 |
Why?
|
Diet | 1 | 2015 | 7937 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12244 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12356 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2011 | 57776 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 56429 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15535 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18373 | 0.010 |
Why?
|
Child | 2 | 2011 | 77709 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2011 | 77460 | 0.010 |
Why?
|
Obesity | 1 | 2014 | 12746 | 0.010 |
Why?
|
Child, Preschool | 1 | 2010 | 41005 | 0.000 |
Why?
|